Galadlas, Honey Mae P.

HRN: 19-81-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2024
CEFTRIAXONE 1G (VIAL)
10/22/2024
10/28/2024
IVT
1.5gm
OD
UTI
Waiting Final Action 
10/22/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/22/2024
10/28/2024
PO
1mL
Q6
Oral Sores
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: